260 related articles for article (PubMed ID: 15544810)
1. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
[TBL] [Abstract][Full Text] [Related]
2. Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein.
Saunders HM; Gilis D; Rooman M; Dehouck Y; Robertson AL; Bottomley SP
Protein Sci; 2011 Oct; 20(10):1675-81. PubMed ID: 21780213
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3.
Chow MK; Mackay JP; Whisstock JC; Scanlon MJ; Bottomley SP
Biochem Biophys Res Commun; 2004 Sep; 322(2):387-94. PubMed ID: 15325242
[TBL] [Abstract][Full Text] [Related]
4. Functional interactions as a survival strategy against abnormal aggregation.
Masino L; Nicastro G; Calder L; Vendruscolo M; Pastore A
FASEB J; 2011 Jan; 25(1):45-54. PubMed ID: 20810784
[TBL] [Abstract][Full Text] [Related]
5. The Josephin domain determines the morphological and mechanical properties of ataxin-3 fibrils.
Masino L; Nicastro G; De Simone A; Calder L; Molloy J; Pastore A
Biophys J; 2011 Apr; 100(8):2033-42. PubMed ID: 21504740
[TBL] [Abstract][Full Text] [Related]
6. The Machado-Joseph disease-associated expanded form of ataxin-3: Overexpression, purification, and preliminary biophysical and structural characterization.
Contessotto MGG; Rosselli-Murai LK; Garcia MCC; Oliveira CLP; Torriani IL; Lopes-Cendes I; Murai MJ
Protein Expr Purif; 2018 Dec; 152():40-45. PubMed ID: 30036587
[TBL] [Abstract][Full Text] [Related]
7. Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3.
Gales L; Cortes L; Almeida C; Melo CV; Costa MC; Maciel P; Clarke DT; Damas AM; Macedo-Ribeiro S
J Mol Biol; 2005 Oct; 353(3):642-54. PubMed ID: 16194547
[TBL] [Abstract][Full Text] [Related]
8. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3.
Berke SJ; Schmied FA; Brunt ER; Ellerby LM; Paulson HL
J Neurochem; 2004 May; 89(4):908-18. PubMed ID: 15140190
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel site of interaction between ataxin-3 and the amyloid aggregation inhibitor polyglutamine binding peptide 1.
Knight PD; Karamanos TK; Radford SE; Ashcroft AE
Eur J Mass Spectrom (Chichester); 2018 Feb; 24(1):129-140. PubMed ID: 29334808
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.
Haacke A; Broadley SA; Boteva R; Tzvetkov N; Hartl FU; Breuer P
Hum Mol Genet; 2006 Feb; 15(4):555-68. PubMed ID: 16407371
[TBL] [Abstract][Full Text] [Related]
11. Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
Matos CA; de Macedo-Ribeiro S; Carvalho AL
Prog Neurobiol; 2011 Sep; 95(1):26-48. PubMed ID: 21740957
[TBL] [Abstract][Full Text] [Related]
12. Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3.
Nicastro G; Todi SV; Karaca E; Bonvin AM; Paulson HL; Pastore A
PLoS One; 2010 Aug; 5(8):e12430. PubMed ID: 20865150
[TBL] [Abstract][Full Text] [Related]
13. The conformational ensemble of the disordered and aggregation-protective 182-291 region of ataxin-3.
Invernizzi G; Lambrughi M; Regonesi ME; Tortora P; Papaleo E
Biochim Biophys Acta; 2013 Nov; 1830(11):5236-47. PubMed ID: 23891935
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.
Mao Y; Senic-Matuglia F; Di Fiore PP; Polo S; Hodsdon ME; De Camilli P
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12700-5. PubMed ID: 16118278
[TBL] [Abstract][Full Text] [Related]
15. Protein Environment: A Crucial Triggering Factor in Josephin Domain Aggregation: The Role of 2,2,2-Trifluoroethanol.
Visentin C; Navarro S; Grasso G; Regonesi ME; Deriu MA; Tortora P; Ventura S
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042316
[TBL] [Abstract][Full Text] [Related]
16. Mode of substrate recognition by the Josephin domain of ataxin-3, which has an endo-type deubiquitinase activity.
Satoh T; Sumiyoshi A; Yagi-Utsumi M; Sakata E; Sasakawa H; Kurimoto E; Yamaguchi Y; Li W; Joazeiro CA; Hirokawa T; Kato K
FEBS Lett; 2014 Nov; 588(23):4422-30. PubMed ID: 25448680
[TBL] [Abstract][Full Text] [Related]
17. [Polyglutamine-expanded ataxin-3 is degraded by autophagy].
Xiao H; Tang J; Hu Z; Tan J; Tang B; Jiang Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):23-8. PubMed ID: 20140862
[TBL] [Abstract][Full Text] [Related]
18. The role of the central flexible region on the aggregation and conformational properties of human ataxin-3.
Santambrogio C; Frana AM; Natalello A; Papaleo E; Regonesi ME; Doglia SM; Tortora P; Invernizzi G; Grandori R
FEBS J; 2012 Feb; 279(3):451-63. PubMed ID: 22129356
[TBL] [Abstract][Full Text] [Related]
19. Destabilization of a non-pathological variant of ataxin-3 results in fibrillogenesis via a partially folded intermediate: a model for misfolding in polyglutamine disease.
Chow MK; Paulson HL; Bottomley SP
J Mol Biol; 2004 Jan; 335(1):333-41. PubMed ID: 14659761
[TBL] [Abstract][Full Text] [Related]
20. Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix.
Perez MK; Paulson HL; Pittman RN
Hum Mol Genet; 1999 Dec; 8(13):2377-85. PubMed ID: 10556285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
